Partial-Breast Radiation for Early Staged Breast Cancers: Hypothesis, Existing Data, and a Planned Phase III Trial

Publisher： Cambridge Scholars Publishing in association with GSE Research

ISSN： 1540-1405

Source： Journal of the National Comprehensive Cancer Network (JNCCN), Vol.3, Iss.3, 2005-05, pp. : 301-307

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II trial of dolastatin-10 in patients with advanced breast cancer

By Perez Edith Hillman David Fishkin Paul Krook James Tan Winston Kuriakose Phillip Alberts Steven Dakhil Shaker

Investigational New Drugs, Vol. 23, Iss. 3, 2005-06 ,pp. : 257-261

Springer Publishing Company

Access to resources Recommend Favorite

Targeting Basal-Like Breast Cancers

Current Drug Targets, Vol. 13, Iss. 12, 2012-11 ,pp. : 1510-1524

Bentham Science Publishers

Access to resources Recommend Favorite

Phase III study of IMC 1121B for metastatic breast cancer begins.

Inpharma, Vol. 1, Iss. 1652, 2008-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Systemic therapy for early-stage HER2-positive breast cancers: Time for a less-is-more approach?

By Paplomata Elisavet Nahta Rita O'Regan Ruth M.

Cancer, Vol. 121, Iss. 4, 2015-02 ,pp. : 517-526

Blackwell Publishing

Access to resources Recommend Favorite

Phase II study of gemcitabine and carboplatin in metastatic breast cancers with prior exposure to anthracyclines and taxanes

By Chan Daniel Yeo Wee-Lee Tiemsim Cordero Maricel Wong Chiung-Ing Chuah Benjamin Soo Ross Tan Sing-Huang Lim Siew-Eng Goh Boon-Cher Lee Soo-Chin

Investigational New Drugs, Vol. 28, Iss. 6, 2010-12 ,pp. : 859-865

Springer Publishing Company

Access to resources Recommend Favorite